This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Better Initial Glycemic Control With Metformin Linked to Longer Effectiveness

Posted: Friday, April 21, 2006

In patients taking metformin as monotherapy to treat type 2 diabetes, achieving a low level of glycosylated hemoglobin level (HbA1c) during the first year predicts a longer period of effectiveness for the medication.

FDA Accepts New Drug Application for Diabetes Drug Galvus

Posted: Friday, April 21, 2006

Clinical studies show significant blood sugar reductions (HbA1c) sustained for one year - Trials also show no association with weight gain; overall incidence of side effects, including hypoglycemia and edema, similar to placebo.

Depo Provera Increase Diabetes Risk in Women

Posted: Thursday, April 20, 2006

Contraception with depo-medroxyprogesterone acetate (DMPA) is associated with an increase in the risk of diabetes in some Latino women with prior gestational diabetes.

Water Retention With Pioglitazone Causes Weight Gain

Posted: Thursday, April 20, 2006

Up to 75 percent of the increase in body weight that can occur in patients with type 2 diabetes who are treated with pioglitazone is from water retention but the drug also tends to reduce abdominal fat and blood pressure.

U.S. Diabetes Population Grows 86 Percent Over Last Decade

Posted: Thursday, March 16, 2006

Research reveals diabetes complications are widespread and growing, and patients desire to gain better control.

Adding a 2nd Glucose Lowering Drug is More Effective than Maximizing a Single Drug

Posted: Monday, March 13, 2006

Major type 2 diabetes study shows significant improvement in blood sugar control and patients demonstrate high adherence and achieve aggressive treatment targets.

Merck Announces FDA Acceptance Of New Drug Application For JANUVIA™

Posted: Thursday, March 09, 2006

JANUVIA is an investigational once-daily medicine with a novel mechanism of action for the treatment of type 2 diabetes.
If approved, JANUVIA would potentially be the first in a new class of oral medications (DPP-4 inhibitors) that enhances the body's own ability to lower blood sugar (glucose) when it is elevated

High Drop Out Rate for Rimonabant Diet

Posted: Tuesday, March 07, 2006

The investigational diet drug Acomplia (rimonabant) has staying power for weight loss and slimmer waists, and can improve lipids, but half of the participants dropped out of the study before the 2-year study was completed.

So Acomplia, which has been widely touted a revolutionary diet drug, seems stymied by the same problem faced by all diet medications-that patients are unwilling to stick with the drug for the long haul

Rimonabant Lowers Weight, Helps Correct Metabolic Syndrome

Posted: Tuesday, March 07, 2006

Results from new 2-year study shows the agent also improved cardiometabolic risk factors even more than the amount of weight loss would have predicted

Actos® Reduced Heart Attacks In People with Type 2 Diabetes

Posted: Monday, November 28, 2005

ACTOS, an oral antidiabetic medication, significantly reduced the combined risk of heart attacks, strokes and death by 16 percent in high-risk patients with type 2 diabetes